From stone tools to steel, from rubber to Kevlar. Humanity's story is written in the materials we've made. Every breakthrough reshapes what's possible. Yet for decades, material science has stood still. The molecules around us have grown predictable. Reliable, but uninspired. Cambrium exists to write the next chapter. Using our Molecular Intelligence, we create novel material building blocks with previously inaccessible functionalities.
| Website | https://cambrium.bio |
| Revenue | $5 million |
| Employees | 26 (23 on RocketReach) |
| Founded | 2020 |
| Address | Rheinsberger Straße 77a, Berlin, Berlin 10115, DE |
| Technologies | |
| Industry | Biotechnology Research |
| Keywords | Biomaterials, Synthetic Biology, Biomanufacturing, Biological Materials, Bio-Based Materials, Biotechnology, Material Science, Advanced Materials, Sustainable Materials, Biotechnology Innovation, Next Generation Materials, Biological Engineering, Green Materials, Renewable Materials, Bio-Based Products, Molecular Engineering, Clean Technology, Environmental Sustainability |
| Competitors | Cargill, DuPont, LanzaTech, Geno, Novozymes, Zymergen, Inc., Amyris, ZymoChem, BIOMILQ, Ecovative Spawn & Substrate - formerly Lambert Spawn Europa +37 more (view full list) |
Looking for a particular Cambrium employee's phone or email?
The Cambrium annual revenue was $5 million in 2026.
Mitchell Duffy is the CEO of Cambrium.
23 people are employed at Cambrium.
Cambrium is based in Berlin, Berlin.